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Heparin, an inhibitor of inositol trisphosphate (InsP,)-induced CaZ+ release in smooth muscle and non-muscle cells, was 
injected into intact frog skeletal muscle fibres. CaZ+ release from the sarcoplasmic reticulum was elicited by the normal 
action potential mechanism and monitored by both fura- fluorescence and an intrinsic birefringence signal. Both optical 
signals, and hence Cd+ release, were unaffected by high concentrations of heparin. This result argues against a major 
physiological role of InsP, as a chemical messenger of excitation-contraction coupling in skeletal muscle. 
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1. INTRODUCTION 
The enigma of excitation-contraction (E-C) 
coupling in skeletal muscle - how depolarization 
of the transverse tubular membranes causes the 
release of Ca’+ from the sarcoplasmic reticulum 
(SR) - remains one of the major problems of mus- 
cle physiology [l]. One of the two prevalent 
hypotheses is that depolarization releases a 
chemical messenger that opens Ca’+ channels in 
the membranes of the SR, while according to the 
other, an electrical charge movement is directly 
coupled to a conformational change that opens 
these channels [2]. The discovery that InsP3 
releases Ca2+ from the endoplasmic reticulum (ER) 
in non-muscle cells [3] rapidly led to suggestions 
that InsP3 may also be the postulated chemical 
messenger for E-C coupling [4,5]. 
In smooth muscle, agonists can induce Ca2+ 
release from the SR independently of changes in 
the surface membrane potential, and it has been 
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suggested that this pharmaco-mechanical Ca2+ 
release is mediated by InsP3 [6,7]. More recently, 
heparin was shown to inhibit InsP3 binding to 
cerebral receptors [Sj and to block InsPs-induced 
Ca2+ release in liver [9], pancreas [lo] and smooth 
muscle [ 1 l] cells. The purpose of the present study 
was to determine whether heparin also blocks the 
normal E-C coupling mechanism in skeletal mus- 
cle, as might be expected if InsP3 were the 
physiological messenger. 
2. MATERIALS AND METHODS 
Intact single twitch fibres were dissected from leg muscles 
(semi-tendinosus and iliofibularis) of English frogs (Rana tem- 
poraria) and mounted in a transparent chamber on an optical 
bench apparatus for measurement of optical signals related to 
E-C coupling [12,13]. In order to minimize contributions from 
movement artifacts in the optical records, the fibres were stret- 
ched to long sarcomere spacing (3.8-4.3 pm) and lowered onto 
pedestal supports. To examine the effect of heparin on Ca*+ 
release from the sarcoplasmic reticulum, single fibres were im- 
paled with a glass micropipette containing a mixture of heparin 
and the ‘free acid’ form of the Ca*+-indicator dye fura-2. This 
mixture was then introduced directly into the myoplasmic space 
by means of air pressure applied to the back end of the micro- 
pipette. The Ringer’s solution bathing the fibres contained (in 
mM): 120 NaCl, 2.5 KCl, 11.8 CaCl2 and 5 NalPipes [sodium 
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salt of piperazine-N,N’-bis(2-ethanesulphonic a id), pH 7.11, 
at 16°C. The use of the high-Ca*+ Ringer’s solution has been 
found to improve generally fibre viability following micro- 
injection, without significantly altering the amplitude and time 
course of Ca*+ release from the SR when stimulated by a single 
action potential [ 131. Only fibres that gave all-or-none optical 
responses to action potentials generated by point electrical 
stimulation were used. 
The heparin used in the experiments was of low molecular 
weight (Mr 4000-6000; product H5640, from Sigma, St. Louis, 
MO) and was from the same lots as found to have a strong 
blocking action on InsP,-stimulated Ca*+ release from smooth 
muscle SR [ll]. Fura- [14] was obtained as the pentapotassium 
salt of the dye (Molecular Probes, Eugene, OR). Its concentra- 
tion in the pipette-injection solution was determined by absor- 
bance measurements made in a spectrophotometer. The 
presence of 4200 #g/ml heparin did not significantly change the 
absorbance spectrum of Ca*+-free fura-2; nor did this large 
concentration have any detectable effect on fura-2’s dissocia- 
tion constant for Ca’+, measured by titration in free [Ca”] 
solutions buffered with EGTA. Two concentrations of heparin 
and fura- were used in the injection solutions: (i) 833 pg/ml 
heparin and 3.6 mM fura-2; (ii) 42OOOgg/ml heparin and 
1.2 mM fura-2. The fura- concentrations in the pipette were 
deliberately kept low in order to avoid the Ca*+-buffering ef- 
fects of high myoplasmic fura- concentrations [13]. 
Three types of fura- signals were measured from the 
heparin/fura-2 injected fibres, with all measurements carried 
out by procedures identical to those described [13]: (i) steady- 
state fura- fluorescence from fibres at rest; (ii) changes in 
fura- fluorescence as a result of electrical stimulation; and (iii) 
changes in fura- absorbance as a result of electrical stimula- 
tion. For these measurements, a 420 ( f 15) nm excitation beam 
from a tungsten-halogen source was selected by means of a 
wide-band interference filter (Omega Optical, Brattleborough, 
VT) positioned between the light source and the muscle fibre. 
Fluorescence was measured with a 495 nm ‘cut-on’ filter 
(06-495; Schott Optical Glass, Duryea, PA) positioned be- 
tween the fibre and the photo-detector (a IN-100 silicon diode; 
E.G. and G., Salem, MA). With these procedures any contribu- 
tion from fibre intrinsic fluorescence was negligible; thus, the 
photo-detector output, when corrected for the band-pass 
overlap of the filters, was proportional to fura- fluorescence. 
Since Ca*+-bound fura- has a negligible fluorescence when ex- 
cited with 420 nm light, the experimental measurements gave 
direct information about Ca*+-free fura- in myoplasm. 
Although the use of a tungsten-halogen light source, which 
emits radiation only weakly below 400 nm, did not maximize 
the signal-to-noise ratio of fura-2’s fluorescence, the resting and 
active dye signals measured by this method were in fact well 
resolved (cf. figs lA,2A). 
For the fura- absorbance measurements, the fibre was trans- 
illuminated with a spot of light (diameter, 50pm), the 
fluorescence cut-on filter was not used, and changes in 420 nm 
light intensity during activity (AI), divided by the steady-state 
value of transmitted light intensity prior to activity (r), were 
measured. Changes in fibre absorbance (AA) were calculated 
according to the equation: 
AA = -(Al/l)/(log,iO) (1) 
In order to obtain the fura-2-related AA, it was necessary to 
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correct the raw measurement at 420 nm for changes in fibre in- 
trinsic absorbance, estimated from analogous AA mea- 
surements made at 480 nm. After correction, the fura-2-related 
component of AA at 420 nm (denoted AA(420)) was calibrated 
in terms of the concentration of Ca*+-fura- complex formed 
during activity (denoted A[CaFura-21) by means of Beer’s law: 
A [CaFura-21 = AA(420)/(Ac(420)/) (2) 
In eqn 2, I denotes the path length of the light within the 
myoplasmic volume and Ae(420) represents the difference in 
molar extinction coefficients of fura- between its Ca*+-bound 
and Ca*+-free forms [13]. 
Given the AA calibration in eqn 2, the simultaneously 
measured fura- fluorescence signals, both at rest and during 
activity, could thus be converted to micromolar concentrations 
of Ca’+-free and Ca*+-bound fura-2, respectively [13]. This 
calibration procedure was important because the heparin con- 
centrations in myoplasm resulting from the pressure injection 
were not directly measured. Rather, heparin concentrations 
were estimated from other measured quantities, namely (i) the 
ratio of concentrations of fura- and heparin in the micro- 
pipette injection solution, and (ii) the total myoplasmic concen- 
trations of fura- obtained as a function of distance from the 
injection site. Although the estimated heparin concentrations 
depend on the value assumed for heparin’s diffusion constant 
in myoplasm (see legend to fig.2B), the peak values estimated 
for the concentration at the injection site (cf. location 0 in 
fig.2B) are likely to be a lower limit of the actual concentra- 
tions. This follows because heparin’s diffusion constant in 
myoplasm is likely to be smaller than that of fura-2, since its 
size (Mr 4000-6000) is considerably larger than that of fura- 
(Mr 637). In all cases, the concentrations of heparin and fura- 
given in section 3 have been referred to the myoplasmic water 
space, under the assumption that myoplasmic water occupies 
70% of fibre volume [15]. 
A second optical signal was also used to assess the effect of 
injected heparin on E-C coupling, namely, the ‘second compo- 
nent’ of the intrinsic birefringence signal [12]. In order to 
measure the birefringence signal, the fibre was positioned be- 
tween crossed polarisers oriented at & 45” with respect to the 
fibre axis and illuminated with 700-750 nm light, a wavelength 
range beyond the absorbance band of fura-2. The birefringence 
signal is reported in units of AI/I, i.e. the change in light inten- 
sity during activity (AI) divided by the resting intensity (I). The 
rising phase, voltage dependence and other properties of this 
birefringence signal are closely similar to those of the 
myoplasmic free [Ca”] transient monitored with 
Ca*+-indicator dyes [16-191. This similarity and other evidence 
[20] indicate that the birefringence signal probably reflects the 
transient binding of Ca*’ to an intrinsic Ca’+ receptor. Thus, 
the birefringence signal and the fura- Ca2+ signal were ex- 
pected to give qualitatively similar indications of the effects of 
heparin on E-C coupling. 
3. RESULTS 
After injection of any water-soluble substance 
into myoplasm, including substances of Mr as high 
as 20000 [21,22], diffusion of the substance 
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establishes a concentration profile as a function of 
distance from the injection site. Thus, the concen- 
tration dependence of possible effects of injected 
substances on the E-C coupling process can be 
estimated in the same fibre at about the same time 
by measuring the optical signals at different 
distances from the injection site. 
Fig.1 shows the fura- fluorescence (panel A) 
and intrinsic birefringence (panel B) signals elicited 
by action potential stimulation, for the fibre con- 
taining the highest concentration of injected 
heparin in these experiments. As observed in the 
absence of heparin [13], the amplitude of the 
[CaFura-21 response was largest at the measure- 
ment site closest to the point of injection (trace 
labelled + 50 pm), where fura- concentration was 
greatest (fig_2A), while at other locations, the 
amplitude of the [CaFura-21 response decreased 
with increasing distance from the injection site. 
The time course of all fura- signals was closely 
similar (time-to-peak about 20 ms after stimula- 
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tion, signal half-width about 60 ms). Moreover, 
signal amplitude at the various locations, assessed 
as either peak value or rate-of-rise, was approx- 
imately linear with fura- concentration (fig.2C), 
as expected for a Ca2+-dye reaction with 1 : 1 
stoichiometry [14] and an underlying free [Ca’+] 
transient that was similar for all fibre locations. 
These features, as well as the absolute amplitude of 
the fura- Ca2+ signals per unit dye concentration, 
are identical to those described for fibres injected 
with fura- alone [13], despite the wide range of 
heparin concentrations involved (see the heparin 
concentration profile estimated in fig.2B). Thus, 
the fura- measurements indicate that injected 
heparin had no detectable effect on the 
myoplasmic free [Ca2+] transient. 
Figs 1B and 2D show that the Ca’+-related com- 
ponent of the birefringence signal (early downward 
deflection in fig.lB) was also very similar in 
amplitude and time course at the different fibre 
locations. (Note that variations in the later time 
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Fig.1. Changes in fura- fluorescence (A) and in intrinsic birefringence (B) recorded at different distances (indicated in pm to the left 
of each trace) from the site of the heparin plus fura- injection. Zero time marks the moment of an external shock. The measurements 
in (A) were made 15-17 min after injection and in (B) 8-10 min after injection. In both parts, the fibre was illuminated with a 90gm 
slit of light oriented transversely to the fibre axis. All traces are single sweeps except for those at location + 50 Frn, which show the 
average of 2 such sweeps taken at the beginning and end of each run. 
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Fig.2. (A) (0) Concentration of Ca’+-free fura- prior to stimulation, [Fura-2] (ordinate), as a function of distance from the 
injection site (abscissa), from the same run as shown in fig.lA. The values of [Fura-2] were estimated from fura-2’s resting fluorescence 
at each measurement location. (0) Best-fit to the fura- concentration profile by means of the one-dimensional diffusion equation: 
[Fura-Z](x,f) cx (1/2)(~&,,t)-0.5exp( -)?)/(4Dappf), where x is distance from the injection site and t is time following injection (cf. 
[13]). The fitted value of II,,,, the apparent diffusion constant of fura- in myoplasm, was 0.47 x 10m6 cm2.s-‘. (B) Myoplasmic 
concentration profile of heparin estimated at 9 min after injection, the time of the measurements in fig.lB. The curve was calculated 
from the one-dimensional diffusion equation using the conservative assumption that the apparent diffusion constant for heparin was 
the same as estimated for fura- in (A). (C) Relationship between the amplitude of the fura-t signal accompanying activity and the 
fura- concentration. Left-hand ordinate: best-fitted scaling factors (A) which relate the amplitude of the rising phase (up to 75% of 
peak value) of the Ca ‘+-fura- signals in fig. 1A to that observed at + 50 pm, the location with the largest measured signal. The 
abscissa plots total fura- concentration in myoplasm, [Fura-2T] (assumed to equal 1.06 x [Fura-21; see [13]), as well as the heparin 
concentration estimated assuming that the ratio of heparin to [Fura-2T] at each point in the diffusion profile was the same as that 
in the injection solution. The dashed line corresponds to a linear relationship between the fitted values and the fura- concentrations. 
Right-hand ordinate: peak value (x) of the Ca’+ -fura- signals in fig.lA vs [Fura-ZT]. The solid line shows the best-fitted line to the 
data. Both rising phase and peak value data were analyzed in order to minimize the effects of indicator saturation associated with 
the relatively large A[CaFura-21 response. (D) Best-fitted scaling factors (A) that relate the amptitude of the ‘rising’ phase (initial 
downward deflection, to 85% of peak value) of the birefringence signals in fig.lB to the average rising phase of the signals measured 
at - 700 and + 800 gm from the site of the heparin/fura-2 injection. The dashed line corresponds to an identical amplitude rising phase 
at all fibre locations (and heparin/fura-2 concentrations). The scatter qbout the line is similar to that seen in fibres not containing 
heparin. The smaller of the two points shown at location +50pm was obtained at 8 min after injection of heparin. 
course of the birefringence signals are attributable 
to movement artifacts accompanying the develop- 
ment of fibre tension). Since the birefringence 
signals observed in this experiment were essentially 
identical to each other and to signals routinely 
observed in un-injected fibres, the birefringence 
measurements confirm that the presence of 
heparin in myoplasm had no significant effect on 
60 
Volume 235, number 1,2 FEBS LETTERS August 1988 
the underlying Ca2+ transient at any concentration 
between 0 and 4000 pug/ml. 
A similar lack of effect on both optical signals 
was observed in 5 other fibres containing injected 
heparin spanning a wide range of concentrations 
(estimated peak values at the injection site at the 
time of the optical measurements of 902, 492, 375, 
42 and 25 pg/ml). 
4. DISCUSSION 
Intracellular heparin, at concentrations as high 
as 4000 pg/ml, was found to be completely ineffec- 
tive in reducing myoplasmic Ca2+ signals resulting 
from the normal E-C coupling process. The 
greatest myoplasmic concentration achieved in 
these experiments is some 300~800-fold larger than 
the I& (the concentration for half-inhibition) of 
InsP3-induced Ca2+ release in smooth muscle, 
5 @g/ml [l I], and in non-muscle cells, 5-15 pg/ml 
[9,10], as well as of InsPJ binding to receptors in 
brain, 5 pg/ml [8]. In contrast, in our intact frog 
skeletal muscle fibres, 5-lo-fold smaller quantities 
of injected ruthenium red, a compound with an 
I& for blocking Ca 2+ release in skeletal muscle 
[23] that is similar (on a molar basis) to the above 
heparin values, effectively blocked the 
Ca’+-related optical signals quantitated by a 
similar method [24]. Thus, we can report with con- 
fidence that heparin has little or no blocking effect 
on the physiological Ca2+ release mechanism in in- 
tact skeletal muscle fibres. 
The low sensitivity and inconsistent response of 
skinned skeletal muscle fibres to applied InsP3 
[25], the very slow contractions evoked by 
photolytic release of InsPs [25], the lack of 
response of intact (not skinned) frog skeletal mus- 
cle fibres to injected InsP3 [26], the low enzyme ac- 
tivity for degradation of InsP3 [27], and the failure 
reported here of heparin to inhibit Ca2+ release 
from the SR constitute a significant body of 
evidence against the hypothesis that InsP3 is the 
chemical messenger of E-C coupling in skeletal 
muscle. It might be argued that this negative 
evidence does not conclusively rule out a 
messenger ole. For example, in the intact fibre 
InsPx-sensitive Ca2+ channels might be localized to 
a compartment not in diffusional contact with in- 
jected InsP3 or heparin but to which ruthenium red 
somehow still has access. Barring demonstration 
of such a compartment, however, the most 
straightforward interpretation of this body of ex- 
perimental results is that IasP does not serve as 
the physiological messenger that triggers CaZf 
release in skeletal muscle. 
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